Efficacy of the ganciclovir implant in the setting of silicone oil vitreous substitute

Retina

Volumn 20, Issue 5, 2000, Pages 520-523

  McGuire, Desmond E ^a   McAulife, Priscilla ^a   Heinemann, Murk Hein ^a   Rahhal, Firas M ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Cytomegalovirus retinitis; Ganciclovir implant; Silicone oil

Indexed keywords

ANTIRETROVIRUS AGENT; GANCICLOVIR; SILICONE OIL;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CLINICAL ARTICLE; CYTOMEGALOVIRUS; DISEASE COURSE; DRUG EFFICACY; DRUG IMPLANT; HUMAN; RETINA DETACHMENT; RETINITIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0034537366     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200005000-00014     Document Type: Article

References (31)

1. Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS)
2. Incidence and natural history of cytomegalovirus in patients with advanced human immunodeficiency virus disease treated with zidovudine
3. Ocular manifestation of acquired immunodeficiency syndrome
4. A randomized controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS
5. A controlled trial of ganciclovir treatment for cytomegalovirus retinopathy: Use of a standardized system for assessment of disease outcome
6. Retinal detachments in patients with cytomegalovirus retinitis
7. Surgical repair of rhegmatogenous retinal detachment in immunocompromised patients with cytomegalovirus retinitis
8. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis
9. Silicone oil in repair of retinal detachments caused by necrotizing retinitis in HIV infection
10. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis
11. Treatment of cytomegalovirus retinitis with dihydroxy propoxymethyl guanine
12. Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies
13. Cytomegalovirus retinitis and response to therapy with ganciclovir
14. Treatment of cytomegalovirus retinopathy with ganciclovir
15. Treatment of cytomegalovirus retinitis with ganciclovir
16. Combined short and long-term therapy for the treatment of cytomegalovirus retinitis using ganciclovir (BW B759U)
17. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: Experience in 314 immunocompromised patients
18. Treatment of cytomegalovirus retinitis with trisodium phosphonoformate hexahydrate (foscarnet)
19. Foscarnet in the treatment of cytomegalovirus in acquired immune deficiency syndrome
20. Foscarnet therapy of cytomegalovirus retinitis in AIDS
21. Foscarnet treatment of cytomegalovirus retinitis in patients with acquired immunodefficiency syndrome
22. Use of intravitreal ganciclovir (dihydroxypropoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS
23. Intravitreal ganciclovir in the treatment of ADS-associated cytomegalovirus retinitis
24. Treatment of cytomegalovirus retinitis with intravitreal ganciclovir: Long-term results
25. Long term intravitreal ganciclovir therapy for cytomegalovirus retinopathy
26. Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome
27. Treatment of cytomegalovirus retinitis with an intraocular sustained release ganciclovir implant
28. Treatment of cytomegalovirus retinitis with a sustained release ganciclovir implant; a multicenter, randomized, controlled trial
29. Risk factors for development of rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis
30. Use of the ganciclovir implant in the treatment of recurrent cytomegalovirus retinitis
31. High dose intravitreal ganciclovir and foscarnet in vitreous and silicone oil filled eyes for the treatment of cytomegalovirus retinitis in AIDS patients